Skip to main content
Fig. 4 | Arthritis Research & Therapy

Fig. 4

From: Cannabinoid type 2 receptor (CB2R) distribution in dermatomyositis skin and peripheral blood mononuclear cells (PBMCs) and in vivo effects of LenabasumTM

Fig. 4

CB2R distribution among DM and HC PBMC populations via flow cytometry. DM and HC PBMCs and skin cells were isolated and stained via flow cytometry. a Percentage of CB2R+ cells among DM CD4+ T cells, CD8+ T cells, CD11c+ mDCs, and CD123+ pDCs. b Percentage of CB2R expression among CD4+ T cells, CD8+ T cells, CD11c+ mDCs, and CD123+ pDCs is compared between HC and DM PBMCs. Graph shows median. *p<0.05, **p<0.01. DM, dermatomyositis; HC, healthy control; mDC, myeloid dendritic cells; PBMC, peripheral blood mononuclear cell; pDC, plasmacytoid dendritic cell

Back to article page